Ulrich Consultants & Investment Group’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Ulrich Consultants & Investment Group’s Portfolio IEIH Stock Details IEIH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-195,142	Closed	-$6.42M	–	71
2022 Q2	$6.42M	Buy	+195,142	New	+$6.4M	3.52%	8

Ulrich Consultants & Investment Group's IEIH Position: Q3 2022 in Review

Ulrich Consultants & Investment Group sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2022, closing a stake of 195,142 shares — an estimated $6.42M sold.

Ulrich Consultants & Investment Group first reported a position in IEIH in Q2 2022 and held it in 1 quarter. The position peaked at $6.42M in Q2 2022. 0 funds tracked by Wall St. Rank hold IEIH as of Q3 2022.

Ulrich Consultants & Investment Group reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2022 after selling out during the quarter.
Ulrich Consultants & Investment Group sold 195,142 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2022, an estimated $6.42M.
Ulrich Consultants & Investment Group first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q2 2022 and held it in 1 quarter.
Ulrich Consultants & Investment Group's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $6.42M in Q2 2022.
0 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2022.

Based on Ulrich Consultants & Investment Group's 13F filing for Q3 2022, filed 8 Nov 2022.